Subpage Banner

HealthTech Stage

HealthTech Stage

INNOVATION, TECHNOLOGY AND PARTNERSHIP

Vibrant, dynamic and representative of the entire spectrum of the medical device supply chain, the HealthTech Stage is where you'll find all the latest news on hardware, software, materials and services. Take a seat and enjoy this engaging two-day conference and seminar programme.

Loading
10:30
  1. A16
    Tactiq Limited and Maddison Ltd
    Maddison is a product design company specialising in medical, scientific and consumer devices and graphical user interfaces (GUIs). They have been operating for over 30 years and have a strong track record in diagnostic and therapy systems, including design of wearables and fluidic devices
10:50
  1. A16
    Albis
    Today, there is a cornucopia of material options available to the producers of medical or diagnostic devices as well as pharmaceutical packaging who plan on using plastics in their applications. The d ...
11:10
  1. A16
    Medtech centre at TRUSTECH

    The NHS faces two challenges in this century. One challenge is to provide high-quality care with dignity to an ageing population, and another to meet increasing demand from the general-population which has growing expectations for what a modern comprehensive healthcare system should provide. Innovation has a crucial role to play in transforming these challenges, and their respective demands on existing resources, into opportunities which can be met in a sustainable manner. It is a good thing that people are living longer, as long as we can enable senior citizens to live healthy and fulfilled lives. Increased demand for healthcare resources is also a good thing if it is focused on improving health outcomes and is a driver for the healthcare system to develop innovative solutions to currently unmet need.

    This talk will outline why the NHS needs to work more closely with innovators both within and outside of the system and the benefits to both parties. Drawing on some examples taken from over 600 innovations which he has assessed during over 10 years working within innovation in the NHS and 15 years prior to that in the private sector, Dr Paul Hanmer will outline key stages in the development of successful MedTech innovations and strategies for engaging with healthcare professionals, provider organisations and patients.

11:30
12:00
  1. A16
    Ultrapolymers
    Increasingly, manufacturers of medical devices are being faced with a need to replace incumbent phthalate-and plasticizer-based materials. What started as a market trend, is now a real need due to regulatory changes coming into effect. This case study looks at inter-material replacement options for flexible PVC, using flexible tubing as the main example but also looks at application developments beyond this market segment. It addresses the topic from a regulatory, technical and commercial point of view, looks at typical application areas and gives an overview of some alternative polymer choices available in the market.
12:20
  1. A16
    David Schnur Associates
12:40
  1. A16
    Centre for Process Innovation (CPI)
13:00
  1. A16
    EG Technology
    Danny Godfrey will use his experience of working with innovators and sitting on various awards committees to talk about how best to prepare your business proposals in order to secure grants.
13:20
  1. A16
14:00
  1. A16
14:20
  1. A16
    The London BioScience Innovation Centre
    Repair or replacement of many human organs still considers as unmet clinical need, including facial organs, trachea or coronary artery bypass grafts. The key important components in the development of these organs are materials can be used as the scaffold. Commercially there are not many materials to be used for human implantation, this is due to toxicity of material, immunological response or do not have the right physiochemical properties. We have developed a family of nanocomposite materials for biomedical application based on functionalised reduced graphene oxide (FRGO). Graphene considers as a wonder material, it is the strongest material on the planet, super-elastic and conductive. The functionalised GO is nontoxic and antibacterial. We functionalised GO and used it as a building block for nanocomposite materials. The materials can be fabricated to human organs with the 3D printer or other fabrication methodologies. The scaffold from these materials is functionalised with bioactive molecules and stem cells technology, so physiologically simulate the human organs. The data for development of organs using these materials will be presented.
14:40
  1. A16
    Ken Block Associates
    Software use within medtech is rapidly expanding, and FDA expectations are also changing. Launching innovative new Medtech products on the US market often hinges on a successful FDA software strategy. ...
15:00
  1. A16
    Minnetronix Inc
    The need to improve speed to market and optimize the use of capital is driving more med-tech companies to consider virtual development. But finding the right partner and effectively managing them can ...
15:20
  1. A16
    Datalink Electronics
10:10
  1. A16
    Worrell Design
    Too often devices are developed with incomplete, biased or unvalidated user inputs—and fail to provide what was truly needed.  Using various techniques, we can objectively generate user needs that cou ...
10:30
  1. A16
    BSI GROUP

Thanks to Our Supporters

Platinum Partners


 

Partners

 

Partners

 

Partners

 

Partners

 

Partners

 

200

Exhibitors

28

Seminars

45

Speakers

2

Days

Opening Times

Wednesday 25 April 2018 9:30 - 17:00
Thursday 26 April 2018 9:30 - 15:00

Add Dates to Calendar